+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Variability within general practitioner prescribing over time



Variability within general practitioner prescribing over time



New Zealand Medical Journal 113(1102): 14-16



We have described intra-general practitioner (GP) prescribing variability over time in terms of volume, cost and average item cost of prescription items, within New Zealand general practice. Longitudinal data over the financial years 1992-94 were studied for two GP samples. Prescription data for a regional sample of 305 GPs were obtained for the first six months (January to June) from the New Zealand pharmaceutical pricing office, Health Benefits Limited. Prescription data from a second national sample of 74 GPs were obtained from the PreMeC prescription analysis (PAS) database of GPs who had participated in three consecutive September to December prescription analyses. The coefficient of variation was used to measure the intra-GP variability over time in total prescription cost, volume of prescription items and average prescription item cost. The median intra-GP variability over time for the regional GP sample, based on reimbursement data, was 9% in total cost, 9% in total volume and 5% in average item cost. The median intra-GP variability in the national sample was very similar to the regional sample when based on reimbursement data, but when PAS data were used the variability was 16% in total cost, 17% in total volume and 8% average item cost. The year-on-year, intra-GP variability for cost was 9%, for volume 9-10% and for average item cost 5-6%. Pharmaceutical budget estimates should reflect year-to-year intra-GP prescribing variability of the order of 9%.

(PDF emailed within 1 workday: $29.90)

Accession: 047920026

Download citation: RISBibTeXText

PMID: 10738495


Related references

Impact of the CSM advice on thioridazine on general practitioner prescribing behaviour in Leeds: time series analysis. British Journal of General Practice 54(502): 370-373, 2004

Prescribing by general practitioner fundholders. Other factors probably explain differences in prescribing. Bmj 312(7034): 849-849, 1996

Developing prevalence-based prescribing units for analysing variations in general practitioner prescribing: a case study using statins. Journal of Clinical Pharmacy and Therapeutics 28(1): 23-29, 2003

General-practitioner prescribing. Journal of the Royal College of General Practitioners 27(175): 79-82, 1977

General practitioner prescribing of erythropoietin. Bmj 303(6809): 1063-1064, 1991

Change in general practitioner prescribing. Age and Ageing 32(2): 231-231, 2003

How much of a general practitioner's prescribing is outside his/her control?. Irish Medical Journal 91(5): 168-172, 1999

General practitioner prescribing at first attendance for diseases. Australian Family Physician 5(1): 99-101, 1976

The general practitioner's information requirements in prescribing. Postgraduate Medical Journal 53(623): 545-547, 1977

General practitioner prescribing rates and costs. New Zealand Medical Journal 93(683): 301-303, 1981

General practitioner prescribing for the driving patient. International Clinical Psychopharmacology 3 Suppl 1: 147-153, 1988

General practitioner prescribing of antibiotics for asthma. British Journal of General Practice 48(436): 1773-1774, 1999

Logical prescribing. A general practitioner's viewpoint. Australian Family Physician 16(7): 919-920, 1987

Hospital consultants an influence on general practitioner prescribing?. Journal of Clinical & Hospital Pharmacy 7(2): 131-136, 1982